| Anti-PD1/PDL1 induced psoriasis D Voudouri, V Nikolaou, K Laschos, A Charpidou, N Soupos, ... Current Problems in Cancer 41 (6), 407-412, 2017 | 107 | 2017 |
| Developments in the treatment of non-small cell lung cancer I Gkiozos, A Charpidou, K Syrigos Anticancer Research 27 (4C), 2823-2827, 2007 | 70 | 2007 |
| Therapy-induced toxicity of the lungs: an overview AG Charpidou, I Gkiozos, S Tsimpoukis, D Apostolaki, KD Dilana, ... Anticancer research 29 (2), 631-639, 2009 | 55 | 2009 |
| Circulating tumor cells count as a predictor of survival in lung cancer K Syrigos, O Fiste, A Charpidou, D Grapsa Critical reviews in oncology/hematology 125, 60-68, 2018 | 50 | 2018 |
| Prospective assessment of clinical risk factors and biomarkers of hypercoagulability for the identification of patients with lung adenocarcinoma at risk for cancer‐associated … K Syrigos, D Grapsa, R Sangare, I Evmorfiadis, AK Larsen, P Van Dreden, ... The oncologist 23 (11), 1372-1381, 2018 | 45 | 2018 |
| CD24: a novel target for cancer immunotherapy E Panagiotou, NK Syrigos, A Charpidou, E Kotteas, IA Vathiotis Journal of Personalized Medicine 12 (8), 1235, 2022 | 41 | 2022 |
| EGFR mutations in non-small cell lung cancer-clinical implications A Charpidou, D Blatza, E Anagnostou, KN Syrigos in vivo 22 (4), 529-536, 2008 | 40 | 2008 |
| Phase II study of gemcitabine plus docetaxel as second-line treatment in malignant pleural mesothelioma: a single institution study I Tourkantonis, N Makrilia, M Ralli, C Alamara, I Nikolaidis, S Tsimpoukis, ... American journal of clinical oncology 34 (1), 38-42, 2011 | 37 | 2011 |
| Venous thromboembolism in patients diagnosed with lung cancer E Salla, EP Dimakakos, S Tsagkouli, I Giozos, A Charpidou, E Kainis, ... Angiology 67 (8), 709-724, 2016 | 33 | 2016 |
| Heparin-induced thrombocytopenia: pathophysiology, diagnosis and management V Patriarcheas, A Pikoulas, M Kostis, A Charpidou, E Dimakakos Cureus 12 (3), 2020 | 31 | 2020 |
| Psychological correlates of sleep quality in lung cancer patients under chemotherapy: a single‐center cross‐sectional study D Papadopoulos, M Kiagia, A Charpidou, I Gkiozos, K Syrigos Psycho‐Oncology 28 (9), 1879-1886, 2019 | 29 | 2019 |
| Wedge resection and segmentectomy in patients with stage I non-small cell lung carcinoma K Reveliotis, G Kalavrouziotis, K Skevis, A Charpidou, R Trigidou, ... Oncology Reviews 8 (2), 2014 | 28 | 2014 |
| Levels of vascular endothelial growth factor in serum and pleural fluid are independent predictors of survival in advanced non-small cell lung cancer: Results of a prospective … I Gkiozos, S Tsagouli, A Charpidou, D Grapsa, E Kainis, C Gratziou, ... Anticancer Research 35 (2), 1129-1137, 2015 | 27 | 2015 |
| Khorana score: νew predictor of early mortality in patients with lung adenocarcinoma I Vathiotis, EP Dimakakos, P Boura, A Ntineri, A Charpidou, G Gerotziafas, ... Clinical and Applied Thrombosis/Hemostasis 24 (8), 1347-1351, 2018 | 26 | 2018 |
| Cardiopulmonary exercise testing (CPET) as preoperative test before lung resection A Kallianos, A Rapti, S Tsimpoukis, A Charpidou, I Dannos, E Kainis, ... in vivo 28 (6), 1013-1020, 2014 | 24 | 2014 |
| The role of metoprolol and enalapril in the prevention of doxorubicin-induced cardiotoxicity in lymphoma patients P Georgakopoulos, M Kyriakidis, A Perpinia, A Karavidas, S Zimeras, ... Anticancer Research 39 (10), 5703-5707, 2019 | 23 | 2019 |
| Pneumonitis related to docetaxel: case report and review of the literature S Alsamarai, AG Charpidou, RA Matthay, D Confeld, KN Syrigos, MW Saif In vivo 23 (4), 635-637, 2009 | 22 | 2009 |
| The effect of anakinra in hospitalized patients with COVID-19: an updated systematic review and meta-analysis KG Kyriakoulis, A Kollias, G Poulakou, IG Kyriakoulis, IP Trontzas, ... Journal of clinical medicine 10 (19), 4462, 2021 | 21 | 2021 |
| Malignant superior vena cava syndrome: state of the art V Patriarcheas, M Grammoustianou, N Ptohis, I Thanou, M Kostis, ... Cureus 14 (1), 2022 | 20 | 2022 |
| Bronchial washing levels of vascular endothelial growth factor receptor-2 (VEGFR2) correlate with overall survival in NSCLC patients A Charpidou, I Gkiozos, M Konstantinou, A Eleftheraki, P Demertzis, ... Cancer letters 304 (2), 144-153, 2011 | 20 | 2011 |
